Press release
Acromegaly Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Pipeline Drugs, Epidemiology and Companies by DelveInsight | Paltusotine (CRN 00808), CAM-2029 (octreotide subcutaneous depo
Acromegaly Market
(Albany, USA) DelveInsight's "Acromegaly Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Acromegaly, historical and forecasted epidemiology as well as the Acromegaly market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Acromegaly market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Acromegaly market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Acromegaly treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Acromegaly market.
Request for a Free Sample Report @ Acromegaly Market Forecast [https://www.delveinsight.com/report-store/acromegaly-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some facts of the Acromegaly Market Report are:
* According to DelveInsight, Acromegaly market size is expected to grow at a decent CAGR by 2032.
* In 2022, the United States had the largest Acromegaly market size of ~USD 700 million among the 7MM countries.
* Leading Acromegaly companies working in the market are Amolyt Pharma, Amryt Pharma Plc, Antisense Therapeutics Ltd, Aquestive Therapeutics Inc, ASCIL Biopharm, Camurus AB, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Debiopharm International SA, DexTech Medical AB, Enesi Pharma Ltd, Foresee Pharmaceuticals Co Ltd, GeneScience Pharmaceuticals Co Ltd, Genevant Sciences Ltd, GlyTech Inc, Ionis Pharmaceuticals Inc, Italfarmaco SpA, OPKO Health Inc, Pharmathen Global BV, Rani Therapeutics LLC, Strongbridge Biopharma plc., and others.
* Key Acromegaly Therapies expected to launch in the market are Paltusotine (CRN 00808), CAM-2029 (octreotide subcutaneous depot), and many others.
* On March 2024, Crinetics Pharmaceuticals announced results of a Randomized, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Paltusotine in Subjects With Non-pharmacologically Treated Acromegaly (PATHFNDR-2)
* On April 2024, Camurus AB announced results of a Phase 3, Open-label, Single-arm, Multi-center Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly
* On September 2023, Pfizer announced results of a non-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Acromegaly Overview
Acromegaly is a rare hormonal disorder caused by excessive production of growth hormone (GH) in adulthood, usually due to a benign tumor in the pituitary gland. This surplus of GH leads to abnormal growth of bones and tissues, resulting in characteristic symptoms such as enlarged hands, feet, and facial features. Other Acromegaly signs include joint pain, thickened skin, and enlarged organs like the heart. If left untreated, acromegaly can lead to serious complications including cardiovascular disease, diabetes, and arthritis. Acromegaly Diagnosis typically involves blood tests to measure GH levels and imaging scans to locate any tumors. Acromegaly Treatment aims to reduce GH production, either through surgery to remove the tumor, medications to suppress hormone release, or radiation therapy in some cases. Regular monitoring is essential to manage symptoms and prevent complications. Early detection and intervention can significantly improve outcomes and quality of life for individuals with acromegaly.
Do you know what will be the Acromegaly market share in 7MM by 2032 @ https://www.delveinsight.com/sample-request/acromegaly-market [https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Acromegaly Market
The Acromegaly market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Acromegaly market trends by analyzing the impact of current Acromegaly therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Acromegaly market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Acromegaly market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Acromegaly market in 7MM is expected to witness a major change in the study period 2019-2032.
Acromegaly Epidemiology
The Acromegaly epidemiology section provides insights into the historical and current Acromegaly patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Acromegaly market report also provides the diagnosed patient pool, trends, and assumptions.
Interested to know how the emerging diagnostic approaches will be contributing in increased Acromegaly diagnosed prevalence pool? Download report @ https://www.delveinsight.com/sample-request/acromegaly-market [https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Acromegaly Drugs Uptake
This section focuses on the uptake rate of the potential Acromegaly drugs recently launched in the Acromegaly market or expected to be launched in 2019-2032. The analysis covers the Acromegaly market uptake by drugs, patient uptake by therapies, and sales of each drug.
Acromegaly Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Acromegaly market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Acromegaly Pipeline Development Activities
The Acromegaly report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Acromegaly key players involved in developing targeted therapeutics.
Download report to know which TOP 3 therapies will be capturing the largest Acromegaly market share by 2032? Click here @ https://www.delveinsight.com/sample-request/acromegaly-market [https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Acromegaly Therapeutics Assessment
Major key companies are working proactively in the Acromegaly Therapeutics market to develop novel therapies which will drive the Acromegaly treatment markets in the upcoming years are Amolyt Pharma, Amryt Pharma Plc, Antisense Therapeutics Ltd, Aquestive Therapeutics Inc, ASCIL Biopharm, Camurus AB, Crinetics Pharmaceuticals Inc, Daewoong Pharmaceutical Co Ltd, Debiopharm International SA, DexTech Medical AB, Enesi Pharma Ltd, Foresee Pharmaceuticals Co Ltd, GeneScience Pharmaceuticals Co Ltd, Genevant Sciences Ltd, GlyTech Inc, Ionis Pharmaceuticals Inc, Italfarmaco SpA, OPKO Health Inc, Pharmathen Global BV, Rani Therapeutics LLC, Strongbridge Biopharma plc., and others.
Do you know how Paltusotine (CRN 00808) and CAM-2029 market launch will be impacting the Acromegaly market CAGR? Download sample report @ https://www.delveinsight.com/sample-request/acromegaly-market [https://www.delveinsight.com/sample-request/acromegaly-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Acromegaly Report Key Insights
1. Acromegaly Patient Population
2. Acromegaly Market Size and Trends
3. Key Cross Competition in the Acromegaly Market
4. Acromegaly Market Dynamics (Key Drivers and Barriers)
5. Acromegaly Market Opportunities
6. Acromegaly Therapeutic Approaches
7. Acromegaly Pipeline Analysis
8. Acromegaly Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Acromegaly Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Acromegaly Competitive Intelligence Analysis
4. Acromegaly Market Overview at a Glance
5. Acromegaly Disease Background and Overview
6. Acromegaly Patient Journey
7. Acromegaly Epidemiology and Patient Population
8. Acromegaly Treatment Algorithm, Current Treatment, and Medical Practices
9. Acromegaly Unmet Needs
10. Key Endpoints of Acromegaly Treatment
11. Acromegaly Marketed Products
12. Acromegaly Emerging Therapies
13. Acromegaly Seven Major Market Analysis
14. Attribute Analysis
15. Acromegaly Market Outlook (7 major markets)
16. Acromegaly Access and Reimbursement Overview
17. KOL Views on the Acromegaly Market
18. Acromegaly Market Drivers
19. Acromegaly Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=acromegaly-market-forecast-2032-fda-ema-pdma-approvals-clinical-trials-pipeline-drugs-epidemiology-and-companies-by-delveinsight-paltusotine-crn-00808-cam2029-octreotide-subcutaneous-depo]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/conference-coverage-services
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acromegaly Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Pipeline Drugs, Epidemiology and Companies by DelveInsight | Paltusotine (CRN 00808), CAM-2029 (octreotide subcutaneous depo here
News-ID: 3493181 • Views: …
More Releases from ABNewswire
Precision Medicine M&A is Transforming the Future of the Biotech Industry
Biotech M&A trends are spotlighting the potential of precision medicine, with companies like Nuvectis Pharma (NASDAQ: NVCT) leading innovations in personalized cancer treatments.
In the ever-evolving landscape of biotechnology, mergers and acquisitions (M&A) are emerging as pivotal mechanisms driving strategic realignments and innovative endeavors. A closer examination of these trends not only unveils the dynamic nature of the industry but also sheds light on the transformative potential of precision medicine. This…
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at E …
Median Overall Survival of 5.49 months observed in patients with a TP53 mutation receiving an Iomab-B led allogeneic bone marrow transplant compared to 1.66 months in patients that did not receive Iomab-B (hazard ratio=0.23, p=0.0002) in the Phase 3 SIERRA Trial - Long-term efficacy results in patients with active relapsed or refractory acute myeloid leukemia also observed in the SIERRA trial
DelveInsight's analysts estimate that relapsed/refractory acute myeloid leukemia market is…
Interior Designer Andy Yates Shares Expert Insights On Podcast
Acclaimed interior designer Andy Yates appeared on the Repco Light Home Improvement Show, sponsored by Benjamin Moore, to kick off a new Q&A segment. Yates answered listener questions about design inspiration, pricing models, and high gloss paint trends, providing valuable insights and practical advice. His participation underscores his commitment to sharing knowledge and fostering a deeper understanding of interior design.
Grand Rapids, MI - Acclaimed interior designer Andy Yates recently appeared…
Eggka Revolutionizes Online Shopping with Exclusive Women's Clothing Collection
Eggka, a trailblazer in the online fashion industry, proudly announces the launch of its new collection, designed to cater to the diverse tastes and preferences of modern women. Renowned for its quality and style, Eggka continues to set benchmarks in the world of online fashion. Discover the latest trends and exclusive pieces by visiting their website at [Eggka](https://www.eggka.com/).
"Our goal is to provide a seamless and enjoyable shopping experience for women…
More Releases for Acromegaly
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
Acromegaly Treatment Market Report Up to 2031
Visiongain has published a new report on Acromegaly Treatment Market Report to 2031: Forecasts By Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Drug Class (Somatostatin Analogs (SSAs) (Somatuline Depot and Other SSAs), Dopamine Agonists (Bromocriptine Mesylate and Other Dopamine Agonists), and Growth Hormone Receptor Antagonist (Somavert)), By Route of Administration (Oral and Parenteral), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online pharmacies) PLUS COVID-19 Recovery Scenarios.
COVID-19 Impact…
Global Acromegaly Market Report Forecast to 2027
Acromegaly is a rare hormonal disease that occurs when the body produces too much growth hormone (GH). The excess GH promotes excessive development in the body's bones and soft tissues. The syndrome causes children to grow to very tall heights. They may also have a disproportionately large bone structure. Acromegaly is a condition that mostly affects the arms, legs, and face.
Get sample copy of this report @ …
Global Acromegaly Market Insights, Forecast
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults. The global Acromegaly market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The…
Acromegaly Treatment Market Opportunity Analysis, 2018-2026
Acromegaly is a rare disorder caused due to the excess production of growth hormone by the pituitary gland, affecting a patient’s physical appearance and internal organs. It is usually caused by benign pituitary tumor (adenoma), however, in rare cases acromegaly symptoms can be observed due to ineffective control of growth hormone-secreting cells by hypothalamus. Abnormal enlargement of hands, arms, feet, legs, and head, and gradual changes in facial features such…
Global Acromegaly Treatment Market (Ectopic Acromegaly & Pseudo Acromegaly)Diagn …
Global acromegaly treatment market was valued at approximately USD +664.0 Million in 2016 and is expected to generate revenue of around USD +838.0 Million by the end of 2022, growing at a CAGR of around +3.94% between 2017 and 2022. There are various symptoms experienced by the patient like the protruded jaw, increased the size of limbs, the spacing between teeth of lower jaw and others. Conditions like hypertension, diabetes,…
